#melanoma

Immunotherapy Combo Improves Melanoma That Has Spread to Brain

His work as a mentor and a sharer of ideas would prepare Chris Eyrich for his new mission as a melanoma advocate.

Melanoma Research Alliance announces $8.2 million for new grant awards to advance melanoma research.

“The more we continue to learn about different areas of the immune system, the more research and development of new drugs we’ll see.”

While Brendan needed no treatment beyond surgery, he knew that it was important to take melanoma—including early stage melanoma—seriously.

The 2018 studies imply that changing the gut microbiome may be a way to increase the likelihood that patients will respond to immunotherapy.

Identifying a tumor’s genetic mutations brings researchers closer to predicting treatment response.

“Our goal is to use the power of lasers to give doctors the same view of individual cells within tissue without having to cut out a biopsy.�...

Chelsea Dawson, an eight-year melanoma survivor, lives with her family in Roanoke, Virginia.

Five ways the tanning and tobacco industries use the same playbook

Researchers are developing better tools to help determine as early as possible whether melanoma tumors are responding to immunotherapies.

She wants to increase awareness of and enrollment in clinical trials so that others can benefit in the ways she has.

Several studies focused on this topic were recently reported on at the AACR-Melanoma Conference.

Although more than 400 melanoma-focused clinical trials are recruiting participants, 1 out of 3 of them will fail due to low enrollment.

Patients receiving pembrolizumab experienced fewer recurrences or deaths.

When taken together, the results of the study indicate that being female is a risk factor for early-onset melanoma.